BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14718401)

  • 1. Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice.
    Yang LL; Gros R; Kabir MG; Sadi A; Gotlieb AI; Husain M; Stewart DJ
    Circulation; 2004 Jan; 109(2):255-61. PubMed ID: 14718401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulated overexpression of the A1-adenosine receptor in mice results in adverse but reversible changes in cardiac morphology and function.
    Funakoshi H; Chan TO; Good JC; Libonati JR; Piuhola J; Chen X; MacDonnell SM; Lee LL; Herrmann DE; Zhang J; Martini J; Palmer TM; Sanbe A; Robbins J; Houser SR; Koch WJ; Feldman AM
    Circulation; 2006 Nov; 114(21):2240-50. PubMed ID: 17088462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrical remodelling precedes heart failure in an endothelin-1-induced model of cardiomyopathy.
    Mueller EE; Momen A; Massé S; Zhou YQ; Liu J; Backx PH; Henkelman RM; Nanthakumar K; Stewart DJ; Husain M
    Cardiovasc Res; 2011 Feb; 89(3):623-33. PubMed ID: 21062919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous endothelin-1 is required for cardiomyocyte survival in vivo.
    Zhao XS; Pan W; Bekeredjian R; Shohet RV
    Circulation; 2006 Aug; 114(8):830-7. PubMed ID: 16908774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined endothelial and myocardial protection by endothelin antagonism enhances transplant allograft preservation.
    Fedak PW; Rao V; Verma S; Ramzy D; Tumiati L; Miriuka S; Boylen P; Weisel RD; Feindel CM
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):407-15. PubMed ID: 15678053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction.
    Amiri F; Virdis A; Neves MF; Iglarz M; Seidah NG; Touyz RM; Reudelhuber TL; Schiffrin EL
    Circulation; 2004 Oct; 110(15):2233-40. PubMed ID: 15466627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of NF-kappaB improves cardiac function and survival without affecting inflammation in TNF-alpha-induced cardiomyopathy.
    Kawamura N; Kubota T; Kawano S; Monden Y; Feldman AM; Tsutsui H; Takeshita A; Sunagawa K
    Cardiovasc Res; 2005 Jun; 66(3):520-9. PubMed ID: 15914117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy.
    Blyszczuk P; Kania G; Dieterle T; Marty RR; Valaperti A; Berthonneche C; Pedrazzini T; Berger CT; Dirnhofer S; Matter CM; Penninger JM; Lüscher TF; Eriksson U
    Circ Res; 2009 Oct; 105(9):912-20. PubMed ID: 19762681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cardiac myocyte-derived endothelin-1 in chagasic cardiomyopathy: molecular genetic evidence.
    Huang H; Yanagisawa M; Kisanuki YY; Jelicks LA; Chandra M; Factor SM; Wittner M; Weiss LM; Pestell RG; Shtutin V; Shirani J; Tanowitz HB
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():263S-266S. PubMed ID: 12193100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyomavirus large T-antigen expression in heart of transgenic mice causes cardiomyopathy.
    Chalifour LE; Gomes ML; Wang NS; Mes-Masson AM
    Oncogene; 1990 Nov; 5(11):1719-26. PubMed ID: 2176284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilated cardiomyopathy in transgenic mice expressing HIV Tat.
    Fang Q; Kan H; Lewis W; Chen F; Sharma P; Finkel MS
    Cardiovasc Toxicol; 2009 Mar; 9(1):39-45. PubMed ID: 19337863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vav promoter-tTA conditional transgene expression system for hematopoietic cells drives high level expression in developing B and T cells.
    Kim WI; Wiesner SM; Largaespada DA
    Exp Hematol; 2007 Aug; 35(8):1231-9. PubMed ID: 17560009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression.
    Kadokami T; McTiernan CF; Kubota T; Frye CS; Feldman AM
    J Clin Invest; 2000 Aug; 106(4):589-97. PubMed ID: 10953034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-dependent expression of matrix proteins in human endothelin-1 transgenic mice.
    Schwarz A; Godes M; Thöne-Reineke C; Theuring F; Bauer C; Neumayer HH; Hocher B
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():39S-43S. PubMed ID: 12193051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional lack of iNOS attenuates diastolic dysfunction in aged ET-1 transgenic mice.
    Kalk P; Westermann D; Herzfeld S; Relle K; Pfab T; Bauer C; Tschöpe C; Stasch JP; Hocher B
    Can J Physiol Pharmacol; 2008 Jun; 86(6):353-7. PubMed ID: 18516098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling during the transition to failure in TNF-alpha over-expressing mice demonstrates the development of autoimmune myocarditis.
    Tang Z; McGowan BS; Huber SA; McTiernan CF; Addya S; Surrey S; Kubota T; Fortina P; Higuchi Y; Diamond MA; Wyre DS; Feldman AM
    J Mol Cell Cardiol; 2004 Apr; 36(4):515-30. PubMed ID: 15081311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy.
    Higuchi Y; McTiernan CF; Frye CB; McGowan BS; Chan TO; Feldman AM
    Circulation; 2004 Apr; 109(15):1892-7. PubMed ID: 15051641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profile in dilated cardiomyopathy caused by elevated frequencies of mitochondrial DNA mutations in the mouse heart.
    Zhang D; Ezekiel UR; Chang SW; Zassenhaus HP
    Cardiovasc Pathol; 2005; 14(2):61-9. PubMed ID: 15780797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
    Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP
    Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional cardiac overexpression of S100A6 attenuates myocyte hypertrophy and apoptosis following myocardial infarction.
    Tsoporis JT; Izhar S; Desjardins JF; Leong-Poi H; Parker TG
    Curr Pharm Des; 2014; 20(12):1941-9. PubMed ID: 23844739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.